SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $34,000 | -96.5% | 200 | -97.6% | 0.00% | -100.0% |
| Q1 2020 | $971,000 | -95.6% | 8,420 | -95.7% | 0.00% | -94.8% |
| Q4 2019 | $22,226,000 | +116878.9% | 194,519 | +69371.1% | 0.08% | – |
| Q2 2019 | $19,000 | -78.2% | 280 | -76.4% | 0.00% | – |
| Q1 2019 | $87,000 | -93.9% | 1,184 | -95.6% | 0.00% | -100.0% |
| Q4 2016 | $1,418,000 | -10.1% | 26,872 | -8.0% | 0.01% | -30.0% |
| Q3 2016 | $1,578,000 | +245.3% | 29,216 | +158.9% | 0.02% | +185.7% |
| Q2 2016 | $457,000 | – | 11,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |